Editorial: Isoniazid-associated hepatitis. Reconsideration of the indications for administration of isoniazid.
D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D004305:Dose-Response Relationship, Drug; D004977:Ethambutol / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D012306:Risk; D014397:Tuberculosis, Pulmonary / Q000517:prevention & control*; D014481:United States
D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin